A Phase I Study of Pazopanib as a Single Agent for Children With Refractory Solid Tumors

Name: A Phase I Study of Pazopanib as a Single Agent for Children With Refractory Solid Tumors
Published: 2010
License: Public Domain

National Cancer Institute (NCI) · 2010

ClinicalTrials.gov · Datasets · License: Public Domain · 2010

Open Source ↗

brain-tumor pharmacokinetics

sarcoma, neuroblastoma, wilms tumor, osteosarcoma, brain tumor, vegf inhibitor, maximum tolerated dose, dose escalation, pharmacokinetics, antitumor activity, pediatric cancer, solid tumor

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 852597
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.